Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Determination of free L-carnitine levels in type II diabetic women with and without complications

European Journal of Clinical Nutrition volume 61, pages 892–895 (2007)Cite this article

Abstract

Background:

Studies on the determination of carnitine levels and nutritional status in patients of type II diabetes.

Objective:

We designed this study to determine changes of serum-free L-carnitine in type II diabetic women.

Design:

A cross-sectional study (case–control study).

Setting:

Clinical of Endocrinology and Metabolism, Sina Hospital, Pharmacological Research Center, Tabriz Medical university, Iran.

Patients and methods:

Taking into account the importance of the control of diabetes, in the present case-control study, the levels of serum-free L-carnitine, blood glucose and lipids, systolic and diastolic blood pressure, body mass index (BMI) and nutritional status assessed in the case and control groups which were selected by the simple sampling method. The control group (n=18) included patients with no complications and the case group (n=33) was grouped into three subgroups including patients with retinopathy, hyperlipidemia and neuropathy.

Results:

Study results indicated that the mean serum-free L-carnitine concentration in the case group was significantly lower than its mean concentration level in the control group, 39.63±8.99 vs 53.42±0.93 μmol/l, respectively (P<0.001). Serum-free L-carnitine in retinopathy, hyperlipidemia and neuropathy case subgroups were 39.03±9.89, 39.63±8.99 and 40.44±12.50 μmol/l, respectively (P>0.05). No significant difference was found between the serum-free carnitine levels of the case subgroups. The mean blood glucose, triglycerides, total cholesterol, low-density lipoprotein cholesterol, very low-density lipoprotein cholesterol levels and systolic and diastolic blood pressure were significantly higher in the case group than in the control group.

Conclusion:

In this study, the mean serum-free L-carnitine levels in diabetic patients with complications was almost 25% lower than in diabetic patients with no complications. On the basis of the study results, carnitine supplementation in diabetic patients, especially in patients with diabetes complications, might be useful.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Similar content being viewed by others

References

  • Akisu M, Kultursay N, Coker I, Huseyinov A (2002). Myocardial and hepatic free carntine concentrations in pups of diabetic female rats. Ann Nutr Metab 46, 45–48.

    Article  CAS  Google Scholar 

  • American Diabetes Association (2003). Management of dyslipidemia in adults with diabetes. Diabetes Care 26, S83–S86.

  • Aoshima S, Fujisawa S, Kobayayashi A (1993). Changes in the subcellular distribution of free carnitine and its acyl derivatives in diabetic rat hearts following treatment with L-carnitine. Jpn Heart J 34, 763–772.

    Article  CAS  Google Scholar 

  • Arrigoni-Martelli E, Caso V (2001). Carnitine protects mitochondria and removes toxic acyls from xenobiotics. Drugs Exp Clin Res 27, 27–49.

    CAS  PubMed  Google Scholar 

  • Brooks SD, Bahl JJ, Bressler R (1985). Carnitine in thestreptozotocin – diabetic rat. J Nutr 115, 1267–1273.

    Article  CAS  Google Scholar 

  • Cattolica CS, Gemelli LA (2004). Carnitine in type 2 diabetes. Ann NY Acad Sci 1033, 99–107.

    Article  Google Scholar 

  • Cederblad G (1987). Effects of diet on plasma carnitine levels and urinary carnitine excretion in humans. Am J Clin Nutr 45, 720–729.

    Article  Google Scholar 

  • Cederblad G, Hermansson G, Ludvigsson J (1982). Plasma and urine carnitine in children with diabetes mellitus. Clin Chim Acta 125, 207–217.

    Article  CAS  Google Scholar 

  • De Grandis D, Minardi C (2002). Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study. Drugs RD 3, 223–231.

    Article  CAS  Google Scholar 

  • Depalo E, Gatti R, Sicolo N, Padovan D, Vetor R, federspil G (1981). Plasma and urine free L-carnitine in human diabetes mellitus. Acta Diabetol Lat 18, 91–95.

    Article  CAS  Google Scholar 

  • Donath MY, Ehses JA, Maedler K, Schumann DM, Ellingsgaard H, Eppler E et al. (2005). Mechanisms of β-Cell Death in Type 2 Diabetes. Diabetes 54, S108–S113.

    Article  CAS  Google Scholar 

  • Gerwald J, Yu-Shan H, Liang T (2005). Crystal structure of mouse carnitine octanoyltransferase and molecular determinants of substrate selectivity. J Biol Chem 280, 744–783.

    Google Scholar 

  • Hoppel CL, Genuth SM (1982). urinary excretion of acetyl carnitine during human diabetic and fasting ketosis. AM J Physiol 243, E168–E172.

    CAS  PubMed  Google Scholar 

  • Inokuchi T, Imamura K, Nomura K, Nomoto K, Isogai S (1995). Changes in carnitine metabolism with ketone body production in obese glucose -intolerant patients. Diab Res Clin Prac 30, 1–7.

    Article  CAS  Google Scholar 

  • Irat AM, Aktan F, Ozansoy G (2003). Effects of L-carnitine treatment on oxidant/antioxidant state and vascular reactivity of streptozotocin-diabetic rat aorta. J Pharm Pharmacol 55, 1389–1395.

    Article  CAS  Google Scholar 

  • Keller VA, Toporoff B, Raziano RM, Pigott JD, Mills NL (1998). Carnitine supplementation improves myocardial function in hearts from ischemic diabetic and euglycemic rats. Ann Thorac Surg 66, 1600–1603.

    Article  CAS  Google Scholar 

  • Morabito E, Serafini S, Corsico N, Martelli AE (1993). Acetyl-L-carnitine effect on nerve conduction velocity in streptozotocin – diabetic rats. Drug Res 43, 343–346.

    CAS  Google Scholar 

  • Okuda Y, Kawi K, Murayama Y, Yamashita K (1987). Postprandial changes in plasma ketone body and carnitine levels in normal and non-insulin –dependent diabetic subjects. Endocrinol Japan 34, 15–22.

    Article  Google Scholar 

  • Pregnant P, Kaiser E, Schernthaner G (1993). Noeffect of insulin treatment or glycemic improvement on plasma carnitine levels in type 2 diabetic patients. Clin Invest 71, 610–612.

    Google Scholar 

  • Seim H, Eichler K, Kleber H (2001). L(-)-Carnitine and its precursor, gamma-butyrobetaine. In: Kramer K, Hoppe P, Packer L (eds) Nutraceuticals in Health and Disease Prevention. New York: Marcel Dekker, Inc. pp 217–256.

    Google Scholar 

  • Shankar SS, Mirzamohammadi B, Walsh JP, Steinberg HO (2004). L-carnitine may attenuate free fatty acid-induced endothelial dysfunction. Ann NY Acad Sci 1033, 189–197.

    Article  CAS  Google Scholar 

  • Stearns SB (1983). Carnitine content of skeletal and cardiac muscle from genitically diabetic and control mice. Biochem Med 29, 57–63.

    Article  CAS  Google Scholar 

  • Steiber A, Kerner J, Hoppel CL (2004). Carnitine: a nutritional, biosynthetic, and functional perspective. Mol Aspects Med 25, 455–473.

    Article  CAS  Google Scholar 

  • Tamamogullart N, Silig Y, Icagasioglu S, Atalay A (1999). Carnitine deficiency in diabetes mellitus complications. J Diab Camp (5/6), 251–253.

    Article  Google Scholar 

  • Vary TC, Neely JR (1982). A mechanism for reduced myocardial carnitine content in diabetic animals. Am J Physiol 243, H154–H158.

    CAS  PubMed  Google Scholar 

  • Weiland OH (1985). Enzymatic uv test for the determination of L-carnitine. In: Bergmeyer HU (ed) 3rd edn, vol VIII, Methods of enzymatic analysis. VCH Verlagsgesellschaft, Weinheim, Deerfield Beach. pp 481–488.

    Google Scholar 

  • Williamson JR, Arrigoni ME, Martelli E (1992). The roles of glucosoinduced metabolic hypoxia and imbalances in carnitine metabolism in mediating diabetes – induced vascular dysfunction. Int J Clin Pharmacol Res 12, 247–252.

    CAS  PubMed  Google Scholar 

  • Winter CS, Simon M, Zorn ME (1987). Relative carnitine insufficiency in children with type I diabetes mellitus. AJDC 143, 1337–1339.

    Google Scholar 

  • Zhou YP, Berggren PO, Grill V (1996). A fatty acid- induced decrease in pyruvate dehydrogenase activity is an important determinant of β- cell dysfunction in the obese diabetic db/db mouse. Diabetes 45, 580–586.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ilam Medical University, Ilam, Iran

    A Poorabbas & F Fallah

  2. Faculty of Nutrition, Tabriz Medical University, Tabriz, Iran

    J Bagdadchi, R Mahdavi, Y Asadi, H Koushavar & M Vahed Jabbari

  3. Tabriz Medical University, Tabriz, Iran

    A Aliasgarzadeh

Authors
  1. A Poorabbas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. F Fallah
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. J Bagdadchi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. R Mahdavi
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. A Aliasgarzadeh
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Y Asadi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. H Koushavar
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. M Vahed Jabbari
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A Poorabbas.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Poorabbas, A., Fallah, F., Bagdadchi, J. et al. Determination of free L-carnitine levels in type II diabetic women with and without complications. Eur J Clin Nutr 61, 892–895 (2007). https://doi.org/10.1038/sj.ejcn.1602594

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ejcn.1602594

Keywords

This article is cited by

Search

Advanced search

Quick links